Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Aqueous Hydrogel to Plaque Psoriasis

NCT02322086 is registered in ClinicalTrials.gov with Provectus Pharmaceuticals as lead sponsor.

NCT NCT02322086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02322086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Aqueous Hydrogel to Plaque Psoriasis
Lead sponsor
Provectus Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2015
Completion date
June 30, 2017
Enrollment
30 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis